Home › Type 1 Diabetes › Tennessee
Pag-aaral pangklinika para sa Type 1 Diabetes sa Tennessee
11 pag-aaral para sa Type 1 Diabetes ang naghahanap ng mga kalahok sa mga site sa Tennessee.
Mga Lungsod sa Tennessee
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- AM Diabetes & Endocrinology Center- Site Number : 8400004, Bartlett
Nagre-recruitPhase 3
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- University Diabetes & Endocrine Consultants, Chattanooga
- Le Bonhuer Children's, Memphis
Nagre-recruitPhase 1/2
Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06783309Sleep Coach for Adolescents With Type 1 Diabetes
- Vanderbilt University Medical Center, Nashville
Nagre-recruit
Edad 11 hanggang 17 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06516614Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Vanderbilt University, Nashville
Nagre-recruitPhase 2
Edad 8 hanggang 45 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07142252Family Intervention for Black Teens With Type 1 Diabetes
- LeBonheur Children's Hospital, Memphis
- University of Tennessee Health Science Center-Memphis, Memphis
Nagre-recruit
Edad 10 hanggang 14 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06275412Registry for Stage 2 Type 1 Diabetes
- AM Diabetes & Endocrinology Center- Site Number : 8400012, Bartlett
- Vanderbilt University Medical Center- Site Number : 8400023, Nashville
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06481904Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Vanderbilt University Medical Center, Nashville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT06852950Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
- Vanderbilt University Medical Center, Nashville
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Dis 23, 2025 · NCT06609356Discovery Diabetes
- Vanderbilt University, Nashville
Nagre-recruit
Edad 13 hanggang 21 · Lahat ng kasarian · Na-update Dis 23, 2025 · NCT07116434GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
- Vanderbilt University Medical Center, Nashville
Nagre-recruitMaagang Phase 1
Edad 12 hanggang 50 · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT06338553TrialNet Pathway to Prevention of T1D
- Vanderbilt University, Nashville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 45 · Lahat ng kasarian · Na-update Hul 1, 2025 · NCT00097292Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.